Please vote for Stuart Peltz, Ph, President and CEO of PTC Therapeutics.
Stu has been has been nominated for R&D Magazine’s Scientist of the Year award. After reviewing candidates’ applications, the editors of R&D Magazine selected seven nominees. Now it is up to the public to choose the 2009 Scientist of the Year.
While PTC is known to our community for PTC124/Ataluren, it is important to understand that there is a great deal more to PTC. They have developed and executed the first pivotal trial of a new compound for DMD and validated the 6 minute walk as a primary outcome measure in DMD. In addition, PTC/PPMD’s Project Catalyst in DMD is moving forward and PTC is moving forward on another compound for DMD. They are committed to change the landscape of Duchenne.
Online voting is open and closes September 4, and the winner will be announced publically at 47th Annual R&D 100 Awards on November 12. If you would like to vote for Stuart, click here!
(The site requires you to register first in order to vote)
PLEASE SPREAD THE WORD!